Reviewed,
UniProtKB/Swiss-Prot Q9HD20 (AT131_HUMAN)
Last modified
November 24, 2009.
Version 87.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Probable cation-transporting ATPase 13A1 EC=3.6.3.- | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1204 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Catalytic activity | ATP + H2O = ADP + phosphate. |
| Subcellular location | Membrane; Multi-pass membrane protein By similarity. |
| Sequence similarities | Belongs to the cation transport ATPase (P-type) family. Type V subfamily. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Membrane |
| Coding sequence diversity | Alternative splicing |
| Domain | Transmembrane |
| Ligand | ATP-binding Magnesium Metal-binding Nucleotide-binding |
| Molecular function | Hydrolase |
| PTM | Glycoprotein Phosphoprotein |
| Technical term | Complete proteome |
| Gene Ontology (GO) | |
| Biological process | ATP biosynthetic process Inferred from electronic annotation. Source: InterPro cation transportInferred from electronic annotation. Source: InterPro |
| Cellular component | integral to membrane Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | ATP binding Inferred from electronic annotation. Source: UniProtKB-KW ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanismInferred from electronic annotation. Source: InterPro magnesium ion bindingInferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] Note: Experimental confirmation may be lacking for some isoforms. | ||||||
| Isoform A (identifier: Q9HD20-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform B (identifier: Q9HD20-2) The sequence of this isoform differs from the canonical sequence as follows: 1-118: Missing. 119-132: HWSVHAHCALTCTP → MEKWEELNSHQPGE | ||||||
| Isoform C (identifier: Q9HD20-3) The sequence of this isoform differs from the canonical sequence as follows: 1-860: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1204 | 1204 | Probable cation-transporting ATPase 13A1 | PRO_0000046421 | |||||
Regions | |||||||||
| Topological domain | 1 – 66 | 66 | Cytoplasmic Potential | ||||||
| Transmembrane | 67 – 87 | 21 | Potential | ||||||
| Topological domain | 88 – 95 | 8 | Extracellular Potential | ||||||
| Transmembrane | 96 – 116 | 21 | Potential | ||||||
| Topological domain | 117 – 243 | 127 | Cytoplasmic Potential | ||||||
| Transmembrane | 244 – 264 | 21 | Potential | ||||||
| Topological domain | 265 – 443 | 179 | Extracellular Potential | ||||||
| Transmembrane | 444 – 464 | 21 | Potential | ||||||
| Topological domain | 465 – 989 | 525 | Cytoplasmic Potential | ||||||
| Transmembrane | 990 – 1010 | 21 | Potential | ||||||
| Topological domain | 1011 | 1 | Extracellular Potential | ||||||
| Transmembrane | 1012 – 1032 | 21 | Potential | ||||||
| Topological domain | 1033 – 1051 | 19 | Cytoplasmic Potential | ||||||
| Transmembrane | 1052 – 1072 | 21 | Potential | ||||||
| Topological domain | 1073 – 1096 | 24 | Extracellular Potential | ||||||
| Transmembrane | 1097 – 1117 | 21 | Potential | ||||||
| Topological domain | 1118 – 1132 | 15 | Cytoplasmic Potential | ||||||
| Transmembrane | 1133 – 1153 | 21 | Potential | ||||||
| Topological domain | 1154 – 1166 | 13 | Extracellular Potential | ||||||
| Transmembrane | 1167 – 1187 | 21 | Potential | ||||||
| Topological domain | 1188 – 1204 | 17 | Cytoplasmic Potential | ||||||
| Compositional bias | 455 – 460 | 6 | Poly-Ala | ||||||
| Compositional bias | 892 – 897 | 6 | Poly-Arg | ||||||
Sites | |||||||||
| Active site | 533 | 1 | 4-aspartylphosphate intermediate By similarity | ||||||
| Metal binding | 864 | 1 | Magnesium By similarity | ||||||
| Metal binding | 868 | 1 | Magnesium By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 899 | 1 | Phosphoserine Ref.7 Ref.8 Ref.10 | ||||||
| Modified residue | 901 | 1 | Phosphothreonine Ref.8 | ||||||
| Modified residue | 935 | 1 | Phosphoserine Ref.9 | ||||||
| Glycosylation | 287 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 420 | 1 | N-linked (GlcNAc...) Ref.6 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 860 | 860 | Missing in isoform C. | VSP_000433 | |||||
| Alternative sequence | 1 – 118 | 118 | Missing in isoform B. | VSP_000434 | |||||
| Alternative sequence | 119 – 132 | 14 | HWSVH…LTCTP → MEKWEELNSHQPGE in isoform B. | VSP_000435 | |||||
Sequences
| ||||||||||||||||||||||||||||||
References
| [1] | "Identification of novel human genes by comparative proteomics." Chou M.C.-H., Lin W.-C. Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B). |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND C). Tissue: Kidney epithelium. |
| [3] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O. DNA Res. 8:85-95(2001) [PubMed: 11347906] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-1204 (ISOFORM A). Tissue: Brain. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 844-1204. Tissue: Brain. |
| [6] | "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry." Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D. J. Proteome Res. 4:2070-2080(2005) [PubMed: 16335952] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-420, MASS SPECTROMETRY. Tissue: Plasma. |
| [7] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-899, MASS SPECTROMETRY. Tissue: Epithelium. |
| [8] | "Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis." Wang B., Malik R., Nigg E.A., Korner R. Anal. Chem. 80:9526-9533(2008) [PubMed: 19007248] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-899 AND THR-901, MASS SPECTROMETRY. |
| [9] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column." Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-935, MASS SPECTROMETRY. |
| [10] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-899, MASS SPECTROMETRY. |
| [11] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [12] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-899, MASS SPECTROMETRY. Tissue: T-cell. |
Cross-references
Sequence databases | |
|---|---|
| AF288687 mRNA. Translation: AAG01173.1. AK026044 mRNA. Translation: BAB15334.1. AK056420 mRNA. Translation: BAG51704.1. AK095287 mRNA. Translation: BAG53019.1. AB058728 mRNA. Translation: BAB47454.1. CH471106 Genomic DNA. Translation: EAW84849.1. CH471106 Genomic DNA. Translation: EAW84850.1. BC009302 mRNA. Translation: AAH09302.2. | |
| IPI | IPI00034277. IPI00218353. IPI00218354. |
| RefSeq | NP_065143.2. |
| UniGene | Hs.501794 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | Q9HD20. |
PTM databases | |
| PhosphoSite | Q9HD20. |
Proteomic databases | |
| PeptideAtlas | Q9HD20. |
| PRIDE | Q9HD20. |
Genome annotation databases | |
| Ensembl | ENST00000357324; ENSP00000349877; ENSG00000105726; Homo sapiens. [Genome view] |
| GeneID | 57130. |
| KEGG | hsa:57130. |
| UCSC | uc002nne.1. human. uc002nng.1. human. uc002nnh.2. human. |
Organism-specific databases | |
| CTD | 57130. |
| GeneCards | GC19M019620. |
| HGNC | HGNC:24215. ATP13A1. |
| PharmGKB | PA134988892. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOGENOM | Q9HD20. |
| HOVERGEN | Q9HD20. |
| OMA | YVYCTEP |
| OrthoDB | EOG905VKM |
Gene expression databases | |
| ArrayExpress | Q9HD20. |
| Bgee | Q9HD20. |
| CleanEx | HS_ATP13A1. |
| Genevestigator | Q9HD20. |
| GermOnline | ENSG00000105726. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR008250. ATPase_P-typ_ATPase-assoc-reg. IPR001757. ATPase_P-typ_ion-transptr. IPR018303. ATPase_P-typ_P_site. IPR006544. ATPase_P-typ_unknown-pump-sp. IPR005834. Dehalogen-like_hydro. [Graphical view] |
| PANTHER | PTHR11939. ATPase_P. 1 hit. |
| Pfam | PF00122. E1-E2_ATPase. 1 hit. PF00702. Hydrolase. 2 hits. [Graphical view] |
| PRINTS | PR00119. CATATPASE. |
| TIGRFAMs | TIGR01494. ATPase_P-type. 3 hits. TIGR01657. P-ATPase-V. 1 hit. |
| PROSITE | PS00154. ATPASE_E1_E2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 63043. |
Entry information
| Entry name | AT131_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9HD20 Secondary accession number(s): B3KPJ2, B3KTA7, Q9H6C6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| SIMILARITY comments Index of protein domains and families |

Clusters with


